BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10886117)

  • 1. Intracranial haemorrhage and use of selective serotonin reuptake inhibitors.
    de Abajo FJ; Jick H; Derby L; Jick S; Schmitz S
    Br J Clin Pharmacol; 2000 Jul; 50(1):43-7. PubMed ID: 10886117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Selective Serotonin Reuptake Inhibitors With the Risk for Spontaneous Intracranial Hemorrhage.
    Renoux C; Vahey S; Dell'Aniello S; Boivin JF
    JAMA Neurol; 2017 Feb; 74(2):173-180. PubMed ID: 27918771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of antidepressants and the risk of haemorrhagic stroke: a nested case control study.
    Douglas I; Smeeth L; Irvine D
    Br J Clin Pharmacol; 2011 Jan; 71(1):116-20. PubMed ID: 21143507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study.
    Martinez C; Rietbrock S; Wise L; Ashby D; Chick J; Moseley J; Evans S; Gunnell D
    BMJ; 2005 Feb; 330(7488):389. PubMed ID: 15718538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressants and the Risk of Hemorrhagic Stroke in the Elderly: a Nested Case-Control Study.
    Schäfer W; Princk C; Kollhorst B; Schink T
    Drug Saf; 2019 Sep; 42(9):1081-1089. PubMed ID: 31165430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction.
    Schlienger RG; Fischer LM; Jick H; Meier CR
    Drug Saf; 2004; 27(14):1157-65. PubMed ID: 15554748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of intracranial haemorrhage in antidepressant users with concurrent use of non-steroidal anti-inflammatory drugs: nationwide propensity score matched study.
    Shin JY; Park MJ; Lee SH; Choi SH; Kim MH; Choi NK; Lee J; Park BJ
    BMJ; 2015 Jul; 351():h3517. PubMed ID: 26173947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction.
    Meier CR; Schlienger RG; Jick H
    Br J Clin Pharmacol; 2001 Aug; 52(2):179-84. PubMed ID: 11488775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk for a first acute coronary syndrome in patients treated with different types of antidepressants: A population based nested case-control study.
    Almog R; Carasso S; Lavi I; Amir O
    Int J Cardiol; 2018 Sep; 267():28-34. PubMed ID: 29957260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Serotonin Reuptake Inhibitors and Risk of Noncardioembolic Ischemic Stroke: A Nested Case-Control Study.
    Alqdwah-Fattouh R; Rodríguez-Martín S; Barreira-Hernández D; Izquierdo-Esteban L; Gil M; González-Bermejo D; Fernández-Antón E; Rodríguez-Miguel A; García-Lledó A; Bolúmar F; de Abajo FJ
    Stroke; 2022 May; 53(5):1560-1569. PubMed ID: 35109681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people.
    Liu B; Anderson G; Mittmann N; To T; Axcell T; Shear N
    Lancet; 1998 May; 351(9112):1303-7. PubMed ID: 9643791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Antidepressant Medications With Incident Type 2 Diabetes Among Medicaid-Insured Youths.
    Burcu M; Zito JM; Safer DJ; Magder LS; dosReis S; Shaya FT; Rosenthal GL
    JAMA Pediatr; 2017 Dec; 171(12):1200-1207. PubMed ID: 29049533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of serotonin-norepinephrine reuptake inhibitors versus selective serotonin reuptake inhibitors on cerebrovascular events.
    Lee YC; Lin CH; Lin MS; Lu Y; Chang CH; Lin JW
    J Clin Psychiatry; 2016 Jan; 77(1):e1-7. PubMed ID: 26845272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of ischemic stroke associated with antidepressant drug use in elderly persons.
    Trifirò G; Dieleman J; Sen EF; Gambassi G; Sturkenboom MC
    J Clin Psychopharmacol; 2010 Jun; 30(3):252-8. PubMed ID: 20473059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures.
    Ziere G; Dieleman JP; van der Cammen TJ; Hofman A; Pols HA; Stricker BH
    J Clin Psychopharmacol; 2008 Aug; 28(4):411-7. PubMed ID: 18626268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction.
    Tata LJ; West J; Smith C; Farrington P; Card T; Smeeth L; Hubbard R
    Heart; 2005 Apr; 91(4):465-71. PubMed ID: 15772201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Seizures Associated with Antidepressant Use in Patients with Depressive Disorder: Follow-up Study with a Nested Case-Control Analysis Using the Clinical Practice Research Datalink.
    Bloechliger M; Ceschi A; Rüegg S; Kupferschmidt H; Kraehenbuehl S; Jick SS; Meier CR; Bodmer M
    Drug Saf; 2016 Apr; 39(4):307-21. PubMed ID: 26650063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study.
    Bak S; Tsiropoulos I; Kjaersgaard JO; Andersen M; Mellerup E; Hallas J; García Rodríguez LA; Christensen K; Gaist D
    Stroke; 2002 Jun; 33(6):1465-73. PubMed ID: 12052976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Intracranial Hemorrhage Associated with the Use of Antidepressants Inhibiting Serotonin Reuptake: A Systematic Review.
    Douros A; Ades M; Renoux C
    CNS Drugs; 2018 Apr; 32(4):321-334. PubMed ID: 29536379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressants and Hepatotoxicity: A Cohort Study among 5 Million Individuals Registered in the French National Health Insurance Database.
    Billioti de Gage S; Collin C; Le-Tri T; Pariente A; Bégaud B; Verdoux H; Dray-Spira R; Zureik M
    CNS Drugs; 2018 Jul; 32(7):673-684. PubMed ID: 29959758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.